A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5)
Clinical trial NCT05526716 · COMPLETED
Trial details
- NCT number
- NCT05526716
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-23
- Primary completion
- 2023-06-21
- Enrollment
- 1080
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.